CANSINO BIOLOGICS INC revenue breakdown overview

CANSINO BIOLOGICS INC revenue for the last year amounted to 379.75 M HKD, the most of which — 394.58 M HKD — came from its highest performing source at the moment, Vaccine Products, the year earlier bringing 1.20 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 377.94 M HKD, and the year before that — 945.14 M HKD.